BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32502131)

  • 1. Ex Vivo Lung Perfusion Improves the Inflammatory Signaling Profile of the Porcine Donor Lung Following Transplantation.
    Stone JP; Ball AL; Crichley W; Yonan N; Liao Q; Sjöberg T; Steen S; Fildes JE
    Transplantation; 2020 Sep; 104(9):1899-1905. PubMed ID: 32502131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial.
    Slama A; Schillab L; Barta M; Benedek A; Mitterbauer A; Hoetzenecker K; Taghavi S; Lang G; Matilla J; Ankersmit H; Hager H; Roth G; Klepetko W; Aigner C
    J Heart Lung Transplant; 2017 Jul; 36(7):744-753. PubMed ID: 28314503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.
    Luo Q; Zhu L; Wang Y; Wang L; Lv W; Hu J
    Ann Transplant; 2019 Dec; 24():647-660. PubMed ID: 31879416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
    Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
    J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.
    Mulloy DP; Stone ML; Crosby IK; Lapar DJ; Sharma AK; Webb DV; Lau CL; Laubach VE; Kron IL
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1208-15. PubMed ID: 22944084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism.
    Charles EJ; Mehaffey JH; Sharma AK; Zhao Y; Stoler MH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1811-1820. PubMed ID: 28483262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion.
    Hsin MKY; Iskender I; Nakajima D; Chen M; Kim H; Dos Santos PR; Sakamoto J; Lee J; Hashimoto K; Harmantas C; Hwang D; Waddell T; Liu M; Keshavjee S; Cypel M
    J Heart Lung Transplant; 2016 Jan; 35(1):130-136. PubMed ID: 26227444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of immediate versus delayed ex-vivo lung perfusion in a porcine cardiac arrest donation model.
    Olbertz C; Pizanis N; Bäumker H; Becker S; Aigner C; Rauen U; Nolte I; Kamler M; Koch A
    Int J Artif Organs; 2019 Jul; 42(7):362-369. PubMed ID: 31238824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donation After Circulatory Death Lungs Transplantable Up to Six Hours After Ex Vivo Lung Perfusion.
    Charles EJ; Huerter ME; Wagner CE; Sharma AK; Zhao Y; Stoler MH; Mehaffey JH; Isbell JM; Lau CL; Tribble CG; Laubach VE; Kron IL
    Ann Thorac Surg; 2016 Dec; 102(6):1845-1853. PubMed ID: 27614736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
    Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
    J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technique for prolonged normothermic ex vivo lung perfusion.
    Cypel M; Yeung JC; Hirayama S; Rubacha M; Fischer S; Anraku M; Sato M; Harwood S; Pierre A; Waddell TK; de Perrot M; Liu M; Keshavjee S
    J Heart Lung Transplant; 2008 Dec; 27(12):1319-25. PubMed ID: 19059112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation.
    Valenza F; Rosso L; Coppola S; Froio S; Palleschi A; Tosi D; Mendogni P; Salice V; Ruggeri GM; Fumagalli J; Villa A; Nosotti M; Santambrogio L; Gattinoni L
    Transpl Int; 2014 Jun; 27(6):553-61. PubMed ID: 24628890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility Study of Pulsatile Left Ventricular Assist Device for Prolonged Ex Vivo Lung Perfusion.
    Schumer EM; Zoeller KA; Linsky PL; Monreal G; Choi Y; Giridharan GA; Sobieski MA; Slaughter MS; van Berkel VH
    Ann Thorac Surg; 2015 Jun; 99(6):1961-7; discussion 1967-8. PubMed ID: 25921254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
    Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of transplant outcome after 24-hour ex vivo lung perfusion using the Organ Care System in a porcine lung transplantation model.
    Sommer W; Salman J; Avsar M; Hoeffler K; Jansson K; Siemeni TN; Knoefel AK; Ahrens L; Poyanmehr R; Tudorache I; Braubach P; Jonigk D; Haverich A; Warnecke G
    Am J Transplant; 2019 Feb; 19(2):345-355. PubMed ID: 30106236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.
    Beller JP; Byler MR; Money DT; Chancellor WZ; Zhang A; Zhao Y; Stoler MH; Narahari AK; Shannon A; Mehaffey JH; Tribble CG; Laubach VE; Kron IL; Roeser ME
    J Heart Lung Transplant; 2020 Jan; 39(1):74-82. PubMed ID: 31761511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion.
    Divithotawela C; Cypel M; Martinu T; Singer LG; Binnie M; Chow CW; Chaparro C; Waddell TK; de Perrot M; Pierre A; Yasufuku K; Yeung JC; Donahoe L; Keshavjee S; Tikkanen JM
    JAMA Surg; 2019 Dec; 154(12):1143-1150. PubMed ID: 31596484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.
    Inci I; Arni S; Iskender I; Citak N; Rodriguez JM; Weisskopf M; Opitz I; Weder W; Frauenfelder T; Krafft MP; Spahn DR
    Cells; 2020 Nov; 9(11):. PubMed ID: 33218154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.